Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities

TK. Kvien, A. Balsa, N. Betteridge, MH. Buch, P. Durez, EG. Favalli, G. Favier, C. Gabay, R. Geenen, I. Gouni-Berthold, F. van den Hoogen, A. Kent, L. Klareskog, M. Ostergaard, K. Pavelka, J. Polido Pereira, AG. Semb, M. Sköld, M. Dougados

. 2020 ; 6 (2) : . [pub] -

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21020424

OBJECTIVE: Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder with a global prevalence of approximately 0.5-1%. Patients with RA are at an increased risk of developing comorbidities (eg, cardiovascular disease, pulmonary disease, diabetes and depression). Despite this, there are limited recommendations for the management and implementation of associated comorbidities. This study aimed to identify good practice interventions in the care of RA and associated comorbidities. METHODS: A combination of primary research (180+ interviews with specialists across 12 European rheumatology centres) and secondary research (literature review of existing publications and guidelines/recommendations) were used to identify challenges in management and corresponding good practice interventions. Findings were prioritised and reviewed by a group of 18 rheumatology experts including rheumatologists, comorbidity experts, a patient representative and a highly specialised nurse. RESULTS: Challenges throughout the patient pathway (including delays in diagnosis and referral, shortage of rheumatologists, limited awareness of primary care professionals) and 18 good practice interventions were identified in the study. The expert group segmented and prioritised interventions according to three distinct stages of the disease: (1) suspected RA, (2) recent diagnosis of RA and (3) established RA. Examples of good practice interventions included enabling self-management (self-monitoring and disease management support, for example, lifestyle adaptations); early arthritis clinic; rapid access to care (online referral, triage, ultrasound-guided diagnosis); dedicated comorbidity specialists; enhanced communication with primary care (hotline, education sessions); and integrating patient registries into daily clinical practice. CONCLUSION: Learning from implementation of good practice interventions in centres across Europe provides an opportunity to more widely improved care for patients with RA and associated comorbidities.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020424
003      
CZ-PrNML
005      
20210830102121.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/rmdopen-2020-001211 $2 doi
035    __
$a (PubMed)32683326
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kvien, Tore K $u Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway t.k.kvien@medisin.uio.no
245    10
$a Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities / $c TK. Kvien, A. Balsa, N. Betteridge, MH. Buch, P. Durez, EG. Favalli, G. Favier, C. Gabay, R. Geenen, I. Gouni-Berthold, F. van den Hoogen, A. Kent, L. Klareskog, M. Ostergaard, K. Pavelka, J. Polido Pereira, AG. Semb, M. Sköld, M. Dougados
520    9_
$a OBJECTIVE: Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder with a global prevalence of approximately 0.5-1%. Patients with RA are at an increased risk of developing comorbidities (eg, cardiovascular disease, pulmonary disease, diabetes and depression). Despite this, there are limited recommendations for the management and implementation of associated comorbidities. This study aimed to identify good practice interventions in the care of RA and associated comorbidities. METHODS: A combination of primary research (180+ interviews with specialists across 12 European rheumatology centres) and secondary research (literature review of existing publications and guidelines/recommendations) were used to identify challenges in management and corresponding good practice interventions. Findings were prioritised and reviewed by a group of 18 rheumatology experts including rheumatologists, comorbidity experts, a patient representative and a highly specialised nurse. RESULTS: Challenges throughout the patient pathway (including delays in diagnosis and referral, shortage of rheumatologists, limited awareness of primary care professionals) and 18 good practice interventions were identified in the study. The expert group segmented and prioritised interventions according to three distinct stages of the disease: (1) suspected RA, (2) recent diagnosis of RA and (3) established RA. Examples of good practice interventions included enabling self-management (self-monitoring and disease management support, for example, lifestyle adaptations); early arthritis clinic; rapid access to care (online referral, triage, ultrasound-guided diagnosis); dedicated comorbidity specialists; enhanced communication with primary care (hotline, education sessions); and integrating patient registries into daily clinical practice. CONCLUSION: Learning from implementation of good practice interventions in centres across Europe provides an opportunity to more widely improved care for patients with RA and associated comorbidities.
650    _2
$a revmatoidní artritida $x epidemiologie $x patologie $7 D001172
650    _2
$a komorbidita $7 D015897
650    _2
$a poskytování zdravotní péče $7 D003695
650    _2
$a lidé $7 D006801
650    _2
$a prevalence $7 D015995
650    _2
$a zajištění kvality zdravotní péče $7 D011785
650    12
$a zlepšení kvality $7 D058996
650    12
$a kvalita zdravotní péče $7 D011787
650    _2
$a self-management $7 D000073278
655    _2
$a časopisecké články $7 D016428
700    1_
$a Balsa, Alejandro $u Hospital Universitario La Paz, Madrid, Spain
700    1_
$a Betteridge, Neil $u Neil Betteridge Associates, London, UK
700    1_
$a Buch, Maya H $u Centre for Musculoskeletal Research, School of Biological Sciences, University of Manchester, Manchester, UK $u Leeds Institute of Rheumatic & Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK
700    1_
$a Durez, Patrick $u Cliniques Universitaires Saint Luc, UCL, Brussels, Belgium
700    1_
$a Favalli, Ennio Giulio $u Rheumatology, Gaetano Pini Institute, Milan, Italy
700    1_
$a Favier, Guillaume $u Leeds Institute of Rheumatic & Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK $u Global Strategy Group, KPMG LLP, London, UK
700    1_
$a Gabay, Cem $u Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland
700    1_
$a Geenen, Rinie $u Utrecht University, Utrecht, Netherlands
700    1_
$a Gouni-Berthold, Ioanna $u University of Cologne, Koln, Germany
700    1_
$a van den Hoogen, Frank $u Radboud University Medical Center Nijmegen, Nijmegen, Netherlands $u Sint Maartenskliniek, Nijmegen, Netherlands
700    1_
$a Kent, Alison $u Salisbury NHS Foundation Trust, Salisbury, UK
700    1_
$a Klareskog, Lars $u Rheumatology, Karolinska Institutet, Stockholm, Sweden
700    1_
$a Ostergaard, Mikkel $u Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Kobenhavn, Denmark
700    1_
$a Pavelka, Karel $u Rheumatologic Clinic, Institute of Rheumatology, Prague, Czech Republic
700    1_
$a Polido Pereira, Joaquim $u Hospital De Santa Maria, Lisboa, Portugal
700    1_
$a Semb, Anne Grete $u Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
700    1_
$a Sköld, Magnus $u Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden $u Department of Respiratory Medicine and Allergy, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden
700    1_
$a Dougados, Maxime $u Hôpital Cochin, Rheumatology, Université Paris Descartes, Paris, France
773    0_
$w MED00188812 $t RMD open $x 2056-5933 $g Roč. 6, č. 2 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32683326 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102121 $b ABA008
999    __
$a ok $b bmc $g 1691073 $s 1140870
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 6 $c 2 $e - $i 2056-5933 $m RMD open $n RMD Open $x MED00188812
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Archiving options